We came across a bullish thesis on Novartis AG (NVS) on Substack by Max Dividends. In this article, we will summarize the bulls’ thesis on NVS. Novartis AG (NVS)'s share was trading at $103.81 as of Nov 26th. NVS’s trailing and forward P/E were 18.12 and 12.67 respectively according to Yahoo Finance.
[caption id="attachment_1196204" align="aligncenter" width="768"]Novartis AG, a Swiss pharmaceutical giant, is a standout for investors seeking steady income streams with its reliable 2.34%...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.